Method
Level · gp.fundamentals.capex_revenue_ratio
Raw value 0.40% · OPTIONAL
· Electromedical & Electrotherapeutic Apparatus
RESEARCH SNAPSHOTIRIDEX CORP's latest supported as-filed period reports revenue of $12.6M. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.capex_revenue_ratio
Raw value 0.40% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value 1.38% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value -7.41% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 77.61% · OPTIONAL
Level · gp.fundamentals.gross_margin
Raw value 34.19% · CORE
Level · gp.fundamentals.operating_margin
Raw value -8.19% · CORE
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 2 independently calculated changes: Gross margin moved 31 bp lower; Operating margin moved 126 bp lower.
2 evidence-backed componentsThis cluster groups 2 independently calculated changes: Inventory increased 15.6%; Inventory / revenue moved 1545 bp higher.
2 evidence-backed componentsThis cluster groups 2 independently calculated changes: Capital expenditure increased 284.6%; Capex / revenue moved 30 bp higher.
2 evidence-backed componentsFree-cash-flow proxy changed +130.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change.
Each point keeps the date investors could first observe it and its accession.
IRIX · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001193125-26-387539SEC ↗8-KSep 2, 2026Period Aug 27, 20260001193125-26-380229SEC ↗4Aug 24, 2026Period Aug 24, 20260001193125-26-362654SEC ↗10-QAug 18, 2026Period Jul 4, 20260001193125-26-355641SEC ↗8-KAug 18, 2026Period Aug 18, 20260001193125-26-355635SEC ↗8-KJul 16, 2026Period Jul 10, 20260001193125-26-305344SEC ↗4Jul 14, 2026Period Jul 10, 20260001193125-26-303346SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Sep 10, 2026Filed Sep 10, 2026 | Dizon Romeo RChief Financial Officer | Open Market PurchaseDirect | 5,100 | $1 | $3,468 | Form 4 ↗ |
| Aug 24, 2026Filed Aug 24, 2026 | Dizon Romeo RChief Financial Officer | Open Market PurchaseDirect | 1,300 | $1 | $973 | Form 4 ↗ |
| Aug 24, 2026Filed Aug 24, 2026 | Dizon Romeo RChief Financial Officer | Open Market PurchaseDirect | 5,368 | $1 | $4,025 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Raw value 7.45% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 1.69% · OPTIONAL
Operating cash flow changed +143.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change.
Net income changed -27.4% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Trade receivables changed -20.5% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Cash & equivalents changed -31.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Operating margin changed -126 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Inventory changed +15.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-07-04. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001193125-26-303280